Policy can help New Hampshire rein in Medicare costs

New Hampshire residents suffering from painful and chronic medical conditions stand to benefit from a federal rule change this year that would offer greater access to treatment for Medicare patients suffering from cancer, diabetes and autoimmune diseases. The new policy, which will open up the market for a type of medication known as biosimilars, could increase patient access to lifesaving care for one of the largest Medicare beneficiary populations in the country.  

Sign up to continue

Print subscriber?     Sign up for Full Access!

Please sign up for as low as 36 cents per day to continue viewing our website.

Digital subscribers receive

  • Unlimited access to all stories from nashuatelegraph.com on your computer, tablet or smart phone.
  • Access nashuatelegraph.com, view our digital edition or use our Full Access apps.

Sign up or Login